TCL Archive Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction” September 11, 1998
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003